ERBB2 and invasive ductal breast carcinoma: Immunohistochemical analysis showed strong, complete membrane staining for HER2/neu oncoprotein in invasive ductal carcinoma cells, with over 10% of tumor cells assigned a HER2/neu score of + 3, reflecting ERBB2 gene amplification.